Our Mission

To provide excellence in patient care and leadership in scientific investigation of cutaneous lymphomas that will lead to greater knowledge and the development of new therapies to improve the survival and the quality of life of our patients.

The Stanford Multidisciplinary Cutaneous and T-cell Lymphoma team offers expert treatment for patients with cutaneous or systemic T-cell lymphomas, including mycosis fungoides (MF), S├ęzary syndrome (SS), CD30+ lymphoproliferative disorders (lymphomatoid papulosis and anaplastic large cell lymphoma), subcutaneous panniculitis- like T-cell lymphoma, gamma-delta T-cell lymphoma, CD8+ aggressive epidermotropic T- cell lymphoma, NK/T-cell lymphoma, other peripheral T-cell lymphomas, and cutaneous B- cell lymphomas. Our physicians subspecialize in treating these types of cancers, and have extensive expertise in handling the most complicated cases. In fact, we serve as the consultants to the experts. Consultations are comprehensive and clinic visits are coordinated to allow joint evaluations by our multidisciplinary team.

Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research
Michael Khodadoust
Assistant Professor of Medicine (Oncology) and of Dermatology
Richard Hoppe
Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)